108 related articles for article (PubMed ID: 3832647)
1. [Adverse effects of non-steroid anti-inflammatory agents. II. Adverse effects of derivatives of aryl-, heteroarylacetic and anthranilic acids].
Janiec W; Pietryka B; Staniewska E; Gołek A
Wiad Lek; 1985 Dec; 38(23):1675-80. PubMed ID: 3832647
[No Abstract] [Full Text] [Related]
2. [Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids].
Janiec W; Pietryka B; Sliwiński L; Leszczyńska J
Wiad Lek; 1985 Nov; 38(22):1613-9. PubMed ID: 2938337
[No Abstract] [Full Text] [Related]
3. [Toxicity and collateral pharmacological effects of A 3: a new non-steroid anti-inflammatory agent].
Chieli T; Fregnan GB; Frigerio L; Vidali M
Boll Chim Farm; 1976 Jan; 115(1):41-57. PubMed ID: 1275978
[No Abstract] [Full Text] [Related]
4. [Collateral and toxic effects of non-steroid antirheumatic drugs].
Fossati C
Clin Ter; 1979 Aug; 90(3):273-305. PubMed ID: 399874
[No Abstract] [Full Text] [Related]
5. [Report from Adverse Effects Board. A new series from the Health Administration's Adverse Effects Board].
Sygeplejersken; 1979 Jun; 79(22):21. PubMed ID: 257861
[No Abstract] [Full Text] [Related]
6. [Flufenamic acid: therapeutic activity and secondary effects].
Schiavetti L
Clin Ter; 1972 Feb; 60(4):359-65. PubMed ID: 4260117
[No Abstract] [Full Text] [Related]
7. Mefenamic acid (ponstel).
Med Lett Drugs Ther; 1967 Oct; 9(20):77-8. PubMed ID: 6052701
[No Abstract] [Full Text] [Related]
8. [Renal calculi containing glaphenine metabolites in a male patient].
Normand M; Cayotte JL; Normand MG; Patouraux C
Nephrologie; 1985; 6(1):33. PubMed ID: 2860577
[No Abstract] [Full Text] [Related]
9. [Safety of antiinflammatory drugs].
Helin-Salmivaara A
Duodecim; 2005; 121(22):2407-10. PubMed ID: 16457071
[No Abstract] [Full Text] [Related]
10. A rheumatologist's view of nonsteroidal anti-inflammatory drugs.
Moore ME
Clin Ther; 1981; 4(3):137-49. PubMed ID: 7030488
[No Abstract] [Full Text] [Related]
11. [Non-steroidal antirheumatics: side-effects and interactions].
Felder M
Schweiz Med Wochenschr; 1982 Aug; 112(35):1209-13. PubMed ID: 6982512
[TBL] [Abstract][Full Text] [Related]
12. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.
Holmes EL
Ann Phys Med; 1966; Suppl():36-49. PubMed ID: 4895006
[No Abstract] [Full Text] [Related]
13. [Gastro-duodenal tolerance of some drugs with analgesic effect. Clinico-endoscopic considerations].
Fichera G; Mirelli E
Minerva Med; 1974 Feb; 65(14):768-77. PubMed ID: 4545237
[No Abstract] [Full Text] [Related]
14. [Drug-induced renal disorders in patients with rheumatoid arthritis].
Nakano M; Nishi S; Ueno M; Saito T; Hasegawa H; Arakawa M
Ryumachi; 1996 Oct; 36(5):775-82. PubMed ID: 8969558
[No Abstract] [Full Text] [Related]
15. [Adverse effects of chemical mediator release inhibitors].
Onoda M; Inokuma S; Ikezawa Z
Nihon Rinsho; 2007 Oct; 65 Suppl 8():259-66. PubMed ID: 18074547
[No Abstract] [Full Text] [Related]
16. [Pharmacological properties of pyrazolone and pyrazolidine derivatives (review of the literature)].
Mokhort NA; Nazarenko NN; Kondratiuk VI
Vrach Delo; 1984 Mar; (3):39-45. PubMed ID: 6372242
[No Abstract] [Full Text] [Related]
17. [Anti-inflammatory drugs: the problem of interactions].
Cervini C; Grassi W; Pauri A; Piergiacomi G
Clin Ter; 1982 Jun; 101(5):459-92. PubMed ID: 6751659
[No Abstract] [Full Text] [Related]
18. Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile.
Ziakas GN; Rekka EA; Gavalas AM; Eleftheriou PT; Tsiakitzis KC; Kourounakis PN
Bioorg Med Chem; 2005 Dec; 13(23):6485-92. PubMed ID: 16185877
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113
[No Abstract] [Full Text] [Related]
20. Non-steroid anti-inflammatory agents.
Br Med J; 1970 Aug; 3(5720):449-51. PubMed ID: 5454326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
